Self-administered Fecal Microbial Transplants-What Could Possibly Go Wrong?

Affiliations

Editorial

Laura E Raffals. Crohns Colitis 360. 2020.

. 2020 Apr 17;2(2):otaa025.

doi: 10.1093/crocol/otaa025. eCollection 2020 Apr.

¹ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

No abstract available

Comment on

Characteristics of Fecal Microbiota Transplantation Use in Inflammatory Bowel Disease Cohort.
Bauer CM, Zhang X, Long MD, Sandler RS. Bauer CM, et al. Crohns Colitis 360. 2020 Apr;2(2):otaa024. doi: 10.1093/crocol/otaa024. Epub 2020 Apr 18. Crohns Colitis 360. 2020. PMID: 32421761 Free PMC article.

1. Quraishi MN, Widlak M, Bhala N, et al. . Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Aliment Pharmacol Ther. 2017;46:479–493. - PubMed
1. Costello SP, Hughes PA, Waters O, et al. . Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA. 2019;321:156–164. - PMC - PubMed
1. Moayyedi P, Surette MG, Kim PT, et al. . Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149:102–109.e6. - PubMed
1. Rossen NG, Fuentes S, van der Spek MJ, et al. . Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology. 2015;149:110–118.e4. - PubMed
1. Paramsothy S, Kamm MA, Kaakoush NO, et al. . Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet (London, England). 2017;389:1218–1228. - PubMed